Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Warnock

Showing results (141-150 of 371) with videos related to

Pageof 38
Sort By:
BMJ (Clinical Research Ed.)|October 19, 2012
Abdominal pain in pregnancyD Jones, J Wilson, N G Warnock, et al.
Biochimica Et Biophysica Acta|July 27, 2001
An Alu cassette in the human epithelial sodium channelY S Oh, S Lee, C Won, et al.
Lancet (London, England)|May 4, 2010
Enzyme replacement therapy for Fabry's diseaseStephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Similar names for similar biologicsNicole Casadevall, Thomas Felix, Bruce E Strober, et al.
Contributions to Nephrology|January 15, 2004
Vascular grafts for hemodialysis: types, sites and techniquesDavid G Warnock, Ashita J Tolwani, Michael Gallichio, et al.
Human Molecular Genetics|May 5, 2023
Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry diseaseValeria Nikolaenko, David G Warnock, Kevin Mills, et al.
Nephron|June 30, 2025
Recent Advances in Understanding the Pathophysiology of Fabry DiseaseDavid G Warnock, Aleš Linhart, Anthony J Bleyer, et al.
Toxicology and Applied Pharmacology|June 15, 1981
Thiamin (vitamin b1) effects on lead intoxication and deposition of lead in tissues: therapeutic potentialG R Bratton, J Zmudzki, M C Bell, et al.
Kidney International Reports|April 11, 2020
Current and Investigational Therapeutics for Fabry DiseaseAndrew Felis, Michael Whitlow, Abigayle Kraus, et al.
The American Journal of Physiology|April 1, 1993
Cytosolic pH sensitivity of an expressed human NHE-1 Na(+)-H+ exchangerK Takaichi, D F Balkovetz, E Van Meir, et al.
Pageof 38

Showing results (141-150 of 371) with videos related to

Sort By:
Pageof 38
BMJ (Clinical Research Ed.)|October 19, 2012
Abdominal pain in pregnancyD Jones, J Wilson, N G Warnock, et al.
Biochimica Et Biophysica Acta|July 27, 2001
An Alu cassette in the human epithelial sodium channelY S Oh, S Lee, C Won, et al.
Lancet (London, England)|May 4, 2010
Enzyme replacement therapy for Fabry's diseaseStephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Similar names for similar biologicsNicole Casadevall, Thomas Felix, Bruce E Strober, et al.
Contributions to Nephrology|January 15, 2004
Vascular grafts for hemodialysis: types, sites and techniquesDavid G Warnock, Ashita J Tolwani, Michael Gallichio, et al.
Human Molecular Genetics|May 5, 2023
Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry diseaseValeria Nikolaenko, David G Warnock, Kevin Mills, et al.
Nephron|June 30, 2025
Recent Advances in Understanding the Pathophysiology of Fabry DiseaseDavid G Warnock, Aleš Linhart, Anthony J Bleyer, et al.
Toxicology and Applied Pharmacology|June 15, 1981
Thiamin (vitamin b1) effects on lead intoxication and deposition of lead in tissues: therapeutic potentialG R Bratton, J Zmudzki, M C Bell, et al.
Kidney International Reports|April 11, 2020
Current and Investigational Therapeutics for Fabry DiseaseAndrew Felis, Michael Whitlow, Abigayle Kraus, et al.
The American Journal of Physiology|April 1, 1993
Cytosolic pH sensitivity of an expressed human NHE-1 Na(+)-H+ exchangerK Takaichi, D F Balkovetz, E Van Meir, et al.
Pageof 38